CRP and lymphopenia: At baseline, most patients being treated with CGRP-mAbs with immunological treatments exhibited normal levels for several inflammatory and hematological markers such as C-reactive protein (CRP), rheumatoid factor (RF), and erythrocyte sedimentation rates (VSG), and did not show lymphopenia.